Rachel Bragg
Corporate Officer/Principal chez PANBELA THERAPEUTICS, INC.
Profil
Rachel Bragg is currently working as the Vice President-Clinical Development at Panbela Therapeutics, Inc. She previously worked as the Director at South Carolina Ovarian Cancer Foundation from 2015 to 2017.
She also worked at PPD, Inc. as the Head-Hematology Oncology.
Postes actifs de Rachel Bragg
| Sociétés | Poste | Début |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2021 |
Anciens postes connus de Rachel Bragg
| Sociétés | Poste | Fin |
|---|---|---|
| South Carolina Ovarian Cancer Foundation | Directeur/Membre du Conseil | 01/01/2017 |
| PPD, INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| South Carolina Ovarian Cancer Foundation | |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
